Choose language:
About us Products Manufacturing Investor Relations Announcements 2008 2007 2006 2005 2004 2003 Annual General Meeting 2008 Share Price Key Figures Financial Calendar Annual & Interim Reports Shareholder Information Investment Calculator Presentations Conference call Analyst Coverage IR Policy Articles of Association Guidelines for Incentive Pay Corporate Governance Contact Media Join Us		Announcements for the Copenhagen Stock Exchange in 2006 21 December 2006 (No. 28-06) Bavarian Nordic A/S provides update on its MVA nef programme against HIV 21 December 2006 (No. 29-06) Bavarian Nordic A/S reports preliminary safety and immunogenicity data from Phase II study with IMVAMUNE®. Vaccine is shown equally immunogenic in HIV-infected and healthy subjects. 19 December 2006 (No. 27-06) Bavarian Nordic A/S issues Financial Calendar for 2007 18 December 2006 (No. 26-06) Bavarian Nordic A/S Receives US Notice of Allowance for New MVA-BN® Patent 22 November 2006 (No. 25-06) U.S. International Trade Commission decides to review Initial Determination issued by the Administrative Law Judge 7 November 2006 (No. 24-06) Bavarian Nordic A/S – Interim Report as of 30 September 2006 30 October 2006 (No. 23-06) MVA-BN®-based vaccine shows promise in breast cancer models 24 October 2006 (No. 22-06) U.S. International Trade Commission Final Determination Extended 23 October 2006 (No. 21-06) Bavarian Nordic initiates Phase I/II clinical trials with MVA-BN® polytope against HIV 8 September 2006 (No. 20-06) Bavarian Nordic explains further on the ITC’s Initial Determination. Invitation to conference call 7 September 2006 (No. 19-06) Bavarian Nordic Patents Infringed According to Initial Ruling at the U.S. International Trade Commission, Company to Appeal Decision on Validity 1 September 2006 (No. 18-06) Bavarian Nordic A/S’ Kvistgård Facility Approved by Authorities 30 August 2006 (No. 17-06) Bavarian Nordic A/S initiates cost savings programme 29 August 2006 (No. 16-06) Bavarian Nordic A/S has been granted another US Patent on MVA 23 August 2006 (No. 15-06) U.S. International Trade Commission Initial Determination Extended 11 August 2006 (No. 14-06) Bavarian Nordic A/S – Interim Report for the period 1 January to 30 June 2006 12 July 2006 (No. 13-06) Bavarian Nordic A/S Issues Revised Financial Calendar 30 June 2006 (No. 12-06) Bavarian Nordic in continued dialogue with possible strategic partners 24 May 2006 (No. 10-06) Bavarian Nordic A/S – Report on the Results of the Extraordinary General Meeting, held 24 May 2006 24 May 2006 (No. 11-06) Bavarian Nordic Establishes New Company in Washington, DC, USA 16 May 2006 (No. 09-06) Bavarian Nordic A/S – Interim Report as of 31 March 2006 3 May 2006 (No. 08-06) Bavarian Nordic A/S – Notice convening extraordinary general meeting 26 April 2006 (No. 06-06) Bavarian Nordic A/S – Information on the Proposal for Changes in the Composition of the Board of Directors 26 April 2006 (No. 07-06) Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held 26 April 2006 7 April 2006 (No. 05-06) Bavarian Nordic A/S – Notice convening ordinary general meeting 31 March 2006 (No. 04-06) Bavarian Nordic A/S – List of stock exchange announcements from 1 January 2005 to 23 March 2006 23 March 2006 (No. 03-06) Capital increase of DKK 5,791,250 (579,125 shares of DKK 10) in Bavarian Nordic A/S finalised 22 March 2006 (No. 02-06) Bavarian Nordic A/S – Annual Results 2005 16 February 2006 (No. 01-06) Bavarian Nordic A/S Further Enforces its Intellectual Property Rights Against Acambis
Home | Sitemap | Disclaimer | Privacy Contact us